Transcatheter Mitral Valve Implantation Market Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2027
A Transcatheter Mitral Valve Implantation Market aims at leveraging the insights and perspectives derived on the basis of both qualitative and quantitative data evaluation for the forecast period, 2020-2027. The market intelligence reports on Transcatheter Mitral Valve Implantation market dives deep into aspects including but not limited to the market size, growth and share across different regions to keep the stakeholders and business owners informed and help them make a wise business decision.
Rise frequency of mitral valve diseases, increasing pioneering pipeline devices together with rising elderly population with heart condition is positively driving the growth prospects of the Transcatheter Mitral Valve Implantation (repair and replacement) market in the forecast period. Mitral Regurgitation (MR) is the greatest widespread valve disorder affecting more than 4 million in total in the United States. Roughly, 250,000 cases of mitral regurgitation are recorded in the United States annually out of which close to 50,000 patients decide to undertake recommended surgery.
Get Free Sample [email protected] https://www.emergenresearch.com/request-sample/54
The primary aim of the report is to offer market overview, product scope, growth prospects, and risks. The report also offers in depth information about each player in the global Transcatheter Mitral Valve Implantation market along with its global standing, financial status, product launch, business expansion plans among others. The market players are focused on developing various strategies such as partnerships, mergers and acquisitions, joint ventures, product launches, and research and development investments.
Companies profiled in the global Transcatheter Mitral Valve Implantation market:
Abbott Laboratories, HLT Medical, Neovasc, Edward Lifesciences, Biotronik Private Limited, LivaNova, Colibri Heart Valve, Medtronic, NeoChord, MValve Technologies, Transcatheter Technologies GmbH and Venus Medtech among other companies Abbott Laboratories, HLT Medical, Neovasc, Edward Lifesciences, Biotronik Private Limited, LivaNova, Colibri Heart Valve, Medtronic, NeoChord, MValve Technologies, Transcatheter Technologies GmbH and Venus Medtech among other companies
Get discount on [email protected] https://www.emergenresearch.com/request-discount/54
Further Key Highlights
- To develop functional (secondary) mitral regurgitation, in March 2019, MitraClip’s suggestions to address the secondary MR was expanded and approved by US Food and Drug Administration (FDA). This can be administered in patients with structural changes in the heart (such as enlargement due to heart failure)
- As mechanical values last long up to approximately 25 years post implant/surgery, mechanical valves segment is anticipated to dominate the industry with a market share of almost, 58.3%
- Mitral Valve Stenosis dominates the market in terms of market share of approximately 44.1% in 2019. However, Mitral Valve Regurgitation segment in the applications outlook registered highest growth rate of approximately 14.1% owing to rise in conditions of mitral regurgitation and due to expansion of potential techniques for successful surgeries
Detailed Regional Analysis covers:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Proceed to [email protected] https://www.emergenresearch.com/select-license/54
For the purpose of this study, Emergen Research have segmented Transcatheter Mitral Valve Implantation Market on the basis of product, application, end use and region:
Product Outlook (Revenue in Million USD; 2017–2027)
- Mechanical Valves
- Bioprosthetic Tissue (Biological) Valves
Application Outlook (Revenue in Million USD; 2017–2027)
- Mitral Valve Stenosis
- Mitral Valve Prolapse
- Mitral Valve Regurgitation
End Use Outlook (Revenue in Million USD; 2017–2027)
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Other
Key Features of the Transcatheter Mitral Valve Implantation Market Report:
- The report offers details about key drivers, restraints, opportunities, challenges, growth prospects, limitations, and threats
- The report encompasses details about the key companies, product portfolio along with specifications, production valuation, and market shares
- Evaluation of key current and emerging market trends and growth prospects
- It also offers research-backed estimations for the forecast period of eight years, primarily to estimate the potential market growth
- Brief overview of industry with regards to research and development, technological advancements, and product development
- In-depth assessment of upstream raw materials, downstream buyers, demands, and current market scenario
Enquire for customization in Report @: https://www.emergenresearch.com/request-for-customization/54
Thank you for reading our report. The report can be customized as per requirement. Please get in touch with us for further inquiry and we will ensure you get the report best suited for your needs.
Explore Similar Reports offered by Emergen Research:
Enzymes [email protected] https://www.emergenresearch.com/industry-report/enzymes-market
Clinical Decision Support Systems (CDSS) [email protected] https://www.emergenresearch.com/industry-report/clinical-decision-support-systems-cdss-market
Cancer Immunotherapy [email protected] https://www.emergenresearch.com/industry-report/cancer-immunotherapy-market
Blockchain in Healthcare [email protected] https://www.emergenresearch.com/industry-report/blockchain-in-healthcare-market
Stem Cell Therapy [email protected] https://www.emergenresearch.com/industry-report/stem-cell-therapy-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
